Exact Mass: 1201.4231770000001
Exact Mass Matches: 1201.4231770000001
Found 53 metabolites which its exact mass value is equals to given mass value 1201.4231770000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(15Z,18Z,21Z,24Z,27Z)-3-oxotriacontapentaenoyl-CoA(4-)
(3R,12Z,15Z,18Z,21Z,24Z,27Z)-3-hydroxytriacontahexaenoyl-CoA(4-)
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)b-GlcNAc
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]a-GalNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)b-GlcNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)b-GlcNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)GlcNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man
Gal(a1-3)GalNAc(a1-3)Gal(b1-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man
Gal(b1-4)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
Gal(a1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
Gal(a1-3)Gal(b1-4)GalNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man
GalNAc(b1-3)Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)b-Glc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-4)GalNAc(b1-3)Gal(b1-4)b-Glc
Gal(a1-4)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)b-Glc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)GalNAc(b1-4)Gal(b1-4)b-Glc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]b-Man
NeuAc(a2-3)GalNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc
Gal(a1-3)GalNAc(a1-3)Gal(b1-3)Gal(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]b-Man
NeuAc(a2-3)GalNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)b-Glc
Gal(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]a-GalNAc
Gal(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
NeuAc(a2-3)GalNAc(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man
NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)[GalNAc(b1-4)]Gal(b1-4)b-Glc
[6)[Neu5Ac(alpha2-6)GalNAc(beta1-4)GlcNAc(beta1-3)]Gal(beta1-3)Gal(beta1-4)Glc(beta1-]n
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-[2-[(E,19R)-19-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyicos-2-enoyl]sulfanylethylamino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate
Gal(b1-4)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]a-GalNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]a-Man
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)Man(b1-4)b-GlcNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]a-Man
GalNAc(b1-4)Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)b-Glc
GlcNAcbeta1-3Galbeta1-4Glcbeta1-6(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta
(3R,12Z,15Z,18Z,21Z,24Z,27Z)-3-hydroxytriacontahexaenoyl-CoA(4-)
A 3-hydroxy fatty acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (3R,12Z,15Z,18Z,21Z,24Z,27Z)-3-hydroxytriacontahexaenoyl-CoA; major species at pH 7.3.
(15Z,18Z,21Z,24Z,27Z)-3-oxotriacontapentaenoyl-CoA(4-)
A 3-oxo-fatty acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (15Z,18Z,21Z,24Z,27Z)-3-oxotriacontapentaenoyl-CoA.
CTAP (TFA)
CTAP TFA is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. CTAP TFA displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP TFA can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction[1][2].